A
Adverum Biotechnologies (ADVM)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Adverum Biotechnologies (ADVM)
Adverum Biotechnologies, Inc. operates as a biotechnology company. The Company focuses on targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitrea... Read more
- USD4.22
- USD4.37
- USD4.01
- USD29.70
- -21.80%
- 1M
- 313.94k
- 208.78k
- 89M
- 4.01
- -50.70%
Stock News
5 hours ago
Companies are expected to post their best earnings growth in 3 years. The biggest gains won’t come from Big Tech.
MarketWatch
yesterday
Jim Cramer says he supports healthcare stocks for their long-term value
CNBC
yesterday
What's behind the move in AI infrastructure stocks — plus, Meta sticks with efficiency mantra
CNBC
yesterday
Eli Lilly shares tumble after cutting its sales outlook. What it means for investors
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
